US National Cancer Institute–China Collaborative Studies on Chinese Medicine and Cancer
Libin Jia(National Institutes of Health), Jeffrey D. White(Stony Brook School), Xiao‐Jiang Hao(Kunming Institute of Botany), Tengfei Ji(Chinese Academy of Medical Sciences & Peking Union Medical College), Ji‐Kai Liu(South Central Minzu University), Joost J. Oppenheim(Frederick National Laboratory for Cancer Research), Zhizheng Zhao(Kunming Institute of Botany), Nancy H. Colburn(Gene Therapy Laboratory), Barry R. O’Keefe(Target (United States)), O. M. Zack Howard(Center for Cancer Research), David Newman(Florida Atlantic University), Weidong Li(China Association of Higher Educaiton), Jie Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Huiting Fan(Guang’anmen Hospital), Ying Zhang(Wuhan University), Hongsheng Lin(Kunming Institute of Botany), Xiao‐Sheng Yang(Kunming Institute of Botany), Matthew R. Young(NYU Langone Health), John A. Beutler(Target (United States)), William L. Farrar(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 11
Related Papers
Plants as a source of anti-cancer agents
|Journal of Ethnopharmacology|2005|2k
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
|Oncogene|2007|1.9k
Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.
|The Journal of Experimental Medicine|1989|765